BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35195815)

  • 1. Effects of cognitive impairment and assisted peritoneal dialysis on exit-site infection in older patients.
    Yabe H; Okada K; Kono K; Imoto Y; Onoyama A; Ito S; Moriyama Y; Kasuga H; Ito Y
    Clin Exp Nephrol; 2022 Jun; 26(6):593-600. PubMed ID: 35195815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Cognitive Impairment Among Peritoneal Dialysis Patients, Impact on Peritonitis and Role of Assisted Dialysis.
    Shea YF; Lam MF; Lee MS; Mok MY; Lui SL; Yip TP; Lo WK; Chu LW; Chan TM
    Perit Dial Int; 2016; 36(3):284-90. PubMed ID: 26634566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Care Peritoneal Dialysis Patients with Cognitive Impairment Have a Higher Risk of Peritonitis in the Second Year.
    Shea YF; Lee MC; Mok MM; Lam MF; Chu LW; Chan FH; Chan TM
    Perit Dial Int; 2019; 39(1):51-58. PubMed ID: 30087176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of CMMSE defined cognitive impairment among peritoneal dialysis patients and its impact on peritonitis.
    Shea YF; Lam MF; Lee MS; Mok MY; Lui SL; Yip TP; Lo WK; Chu LW; Chan TM
    Clin Exp Nephrol; 2016 Feb; 20(1):126-33. PubMed ID: 25995180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.
    Iida H; Kurita N; Fujimoto S; Kamijo Y; Ishibashi Y; Fukuma S; Fukuhara S
    Int Urol Nephrol; 2018 Apr; 50(4):763-769. PubMed ID: 29349637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorhexidine for routine PD catheter exit-site care.
    Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
    Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.
    Htay H; Johnson DW; Craig JC; Schena FP; Strippoli GF; Tong A; Cho Y
    Cochrane Database Syst Rev; 2019 May; 5(5):CD004680. PubMed ID: 31149735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis.
    Rodríguez-Carmona A; Pérez Fontán M; García Falcón T; Fernández Rivera C; Valdés F
    Perit Dial Int; 1999; 19(3):253-8. PubMed ID: 10433162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between types of dressing following catheter insertion and early exit-site infection in peritoneal dialysis.
    Figueiredo AE; de Mattos C; Saraiva C; Olandoski M; Barretti P; Pecoits Filho R; de Moraes TP;
    J Clin Nurs; 2017 Nov; 26(21-22):3658-3663. PubMed ID: 28122398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
    Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
    Boudville N; Johnson DW; Zhao J; Bieber BA; Pisoni RL; Piraino B; Bernardini J; Nessim SJ; Ito Y; Woodrow G; Brown F; Collins J; Kanjanabuch T; Szeto CC; Perl J
    Nephrol Dial Transplant; 2019 Dec; 34(12):2118-2126. PubMed ID: 30053214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of assistance on peritonitis due to breach in aseptic procedure in diabetic patients: A cohort study with the RDPLF data.
    Béchade C; Lanot A; Guillouët S; Ficheux M; Boyer A; Lobbedez T
    Perit Dial Int; 2022 Mar; 42(2):185-193. PubMed ID: 34514906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative-pressure wound therapy is effective for peritoneal dialysis catheter exit-site management in the early postoperative period.
    Fukuzaki H; Nakata J; Nojiri S; Shimizu Y; Kano T; Shirotani Y; Maeda T; Nohara N; Io H; Suzuki Y
    Sci Rep; 2022 Jan; 12(1):70. PubMed ID: 34996968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.